Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: A randomized clinical trial
Hemodialysis International Mar 18, 2018
Khosroshahi HT, et al. - The impact of dietary amylose supplementation in hemodialysis patients was explored herein. Significantly reduced levels of inflammatory and oxidative markers were noted in hemodialysis patients who were given HAM-RS2 for eight weeks.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
